About Calosyn Pharma
Calosyn Pharma is a private company based in Shreveport, Louisiana. It has reported $2,923,077 raised in three offerings on Form D since April 2009. Its chief executive is William Grimes.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Dec 22, 2022 | Mar 7, 2024 | $750,000of $2.0M target | 7 | $107K | DebtRule 506(b) | Form D ↗ |
| Feb 15, 2012 | Feb 29, 2012 | $309,685of $2.1M target | 3 | $103K | Equity06 | Form D ↗ |
| Mar 30, 2009 | Apr 13, 2009amended Apr 13, 2010 | $1,863,392of $3.2M target | 5 | $372K | Equity06 | Form D/A ↗1 earlier filing |
| Total, three offerings | $2,923,077 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Calosyn Pharma's Form D filed Mar 7, 2024.
JL
Joseph Lovett
Director
RB
Richard Babb
Treasurer and director
DW
David Waddell
Director
RB
Ross Barrett
Secretary and director
WG
William Grimes
President and Chief Executive Officer, director
Earlier filings also listed Stephen Snowdy (ceo and director, last listed Feb 2012) and Mike Sherman (director, last listed Feb 2012).